U.S. PHARMACOPEIA

Search USP29  
121 INSULIN ASSAYS
The most prominent manifestation of insulin activity, an abrupt decrease in blood glucose, was the basis for biologic assay from the time of its first clinical use. The procedure, although relatively cumbersome, has the great merit of accurately reflecting the effect on the diabetic patient. The advent of practical yet sophisticated physicochemical methods (e.g., liquid chromatography) to measure insulin potency quantitatively has resulted in a more accurate and precise compendial test for insulin and insulin products. However, the bioidentity of insulin and insulin products cannot be assessed by these methods. Thus, a qualitative test in rabbits is included in this chapter, and its use is called for in the appropriate monographs.
The Rabbit Blood Sugar Method—Quantitative is used to determine the potency of Insulin Reference Standards, for the validation of the stability of new insulin preparations, and to determine the specific activities of insulin analogs.

RABBIT BLOOD SUGAR METHOD—QUANTITATIVE
Diluent— Prepare an aqueous solution containing 0.1% to 0.25% (w/v) of either cresol or phenol, 1.4% to 1.8% (w/v) of glycerin, and sufficient hydrochloric acid to produce a pH between 2.5 and 3.5, unless otherwise directed in the individual monograph.
Standard Stock Solution— Dissolve either a suitable quantity of accurately weighed USP Insulin RS or a vial of lyophilized USP Insulin RS of the appropriate species in Diluent to make a Standard Stock Solution containing 40 USP Insulin Units per mL and having a pH between 2.5 and 3.5, unless otherwise directed in the individual monograph. Store in a cold place, protected from freezing, and use within 6 months.
Standard Solutions— Dilute portions of the Standard Stock Solution with Diluent to make two solutions, one to contain 1.0 USP Insulin Unit per mL (Standard Solution 1), and the other to contain 2.0 USP Insulin Units per mL (Standard Solution 2).
Assay Stock Solution— Proceed as directed under Standard Stock Solution except use a suitable quantity of the preparation under test in place of USP Insulin RS. The Assay Stock Solution contains about 40 USP Insulin Units per mL.
Assay Solutions— Dilute portions of the Assay Stock Solution with Diluent to make two dilutions of the preparation under test, one of which may be expected, on the basis of the assumed potency, to contain 1.0 USP Insulin Unit per mL (Assay Solution 1), and the other to contain 2.0 USP Insulin Units per mL (Assay Solution 2). In the case of neutral insulin injection, adjust to a pH of 2.5 to 3.5 prior to making the dilutions.
Doses of the Solutions To Be Injected— Select on the basis of trial or experience the dose of the dilutions to be injected, the volume of which usually will be between 0.30 mL and 0.50 mL. For each animal the volume of the Standard Solution is the same as that of the Assay Solution.
Preparation of Animal— Select suitable, healthy rabbits each weighing not less than 1.8 kg. Keep the rabbits in the laboratory for not less than 1 week before use in the assay, maintaining them on an adequate uniform diet, with water available at all times.
Procedure— Divide the rabbits into four equal groups of preferably not less than six rabbits each. On the preceding day, approximately 20 hours before the assay, provide each rabbit with an amount of food that will be consumed within 6 hours. Follow the same feeding schedule before each test day. During the assay, withhold all food until after the final blood specimen is taken. Handle the rabbits with care in order to avoid undue excitement, and inject subcutaneously the doses indicated in the following design (see Table 1), the second injection being made on the day after the first injection, or not more than 1 week later. The time between the first and second injection is the same for all rabbits.
Table 1
Group First Injection Second Injection
1 Standard Solution 2 Assay Solution 1
2 Standard Solution 1 Assay Solution 2
3 Assay Solution 2 Standard Solution 1
4 Assay Solution 1 Standard Solution 2
Blood Samples— At 1 hour ± 5 minutes and 2½ hours ± 5 minutes after the time of injection, obtain from each rabbit a suitable blood specimen from a marginal ear vein. Blood can also be collected effectively from the central auricular artery.
Dextrose Determination— Determine the dextrose content of the blood specimens by a suitable procedure that is adapted to automated analysis. The following procedure may be used.
Anticoagulant Solution— Dissolve 1 g of edetate sodium and 200 mg of sodium fluoride in 1 L of water, and mix.
Dextrose Standard Preparations— Transfer known concentrations of USP Dextrose RS to suitable vessels, and dilute quantitatively and stepwise with Anticoagulant Solution (1:9) to obtain a range of Dextrose Standard Solutions containing between 20 and 100 mg per 100 mL, having known concentrations similar to the concentrations in the rabbit blood samples.
Test Preparations— Pipet into separate, suitable vessels 0.1 mL of each Blood Sample and 0.9 mL of Anticoagulant Solution.
Procedure— Subject the Test Preparations to dialysis across a semipermeable membrane for a sufficient time so that the dextrose passes through the membrane into a saline TS solution containing glucose oxidase, horseradish peroxidase, 3-methyl-2-benzothiazolinone hydrazone hydrochloride TS, and N,N-dimethylaniline. The absorbances of the Test Preparations are determined at 600 nm in a recording colorimeter. The absorbances of the Dextrose Standard Preparations are similarly determined at the start and the end of each run.
Calculation Calculate the response of each rabbit to each injection from the sum of the two blood-sugar values, and subtract its response to Standard Solution 1 from that to Standard Solution 2, disregarding the chronological order in which the responses were observed, to obtain the individual differences, y, as shown in the accompanying table.
When the data for one or more rabbits are missing in an assay, allow for differences in the sizes of the groups by suitable means (see Replacement of Missing Values under Design and Analysis of Biological Assays 111).
When the number of rabbits, f, carried through the assay is the same in each group, total the y's in each group and compute Ta = –T1 + T2 + T3 – T4 and Tb = T1 + T2 + T3 + T4. The logarithm of the relative potency of the test dilutions is M¢ = 0.301Ta / Tb. The potency of the injection in USP Units per mL equals the antilog (log R + M¢), where R = vS / vU, in which vS is the number of USP Units per mL of the Standard dilution, and vU is the number of mL of injection per mL of the Assay dilution.
Determine the confidence interval of the log-relative potency M¢ (see Confidence Intervals for Independent Assays under Design and Analysis of Biological Assays 111). If the confidence interval is more than 0.082, which corresponds at P = 0.95 to confidence limits of about ±10% of the computed potency, repeat the assay until the combined data of the two or more assays, redetermined as described in Combination of Independent Assays under Design and Analysis of Biological Assays 111, meet this acceptable limit.
Group Differences Individual Response (y) Total Response (T)
1 Standard solution 2 – Assay solution 1 y1 T1
2 Assay solution 2 – Standard solution 1 y2 T2
3 Assay solution 2 – Standard solution 1 y3 T3
4 Standard solution 2 – Assay solution 1 y4 T4

Bioidentity Test
Proceed as directed for Rabbit Blood Sugar MethodQuantitative with the following modifications:
Procedure— Divide the rabbits into four equal groups of two rabbits each.
Calculation— Proceed as directed for Calculation under Rabbit Blood Sugar MethodQuantitative, but do not determine the confidence interval of the log-relative potency, M¢.
Interpretation— If the potency value obtained is not less than 15 USP Units per mg, the Bioidentity Test requirement is met. If the potency value is less than 15 USP Units per mg, repeat the test using eight more rabbits. If the average potency of the two sets of tests is not less than 15 USP Units per mg, the requirement of the test is met.

Auxiliary Information—
Staff Liaison : Larry N. Callahan, Ph.D., Scientist
Expert Committee : (BBPP05) Biologics and Biotechnology - Proteins and Polysaccharides
USP29–NF24 Page 2544
Pharmacopeial Forum : Volume No. 30(5) Page 1675
Phone Number : 1-301-816-8385